Are Retatrutide and Semaglutide in the same research category?

Yes. Both are catalogued under metabolic pathway research, and they share research areas including Receptor binding assays and In vitro receptor pharmacology. Shared categorisation is not a statement that they behave the same way or that one can replace the other.

Do Retatrutide and Semaglutide need the same storage conditions?

Both are specified at 2–8 °C (lyophilized, sealed) in sealed lyophilized or supplied form, so a single storage location covers both. Always follow the condition printed on the vial label and the published COA for the lot you received.

Which does VaultLabs stock, Retatrutide or Semaglutide?

Both. Retatrutide is listed as 2 catalog skus and Semaglutide as 1 catalog sku, each dispatched from the UAE with lot details you can check through batch verification before ordering.

Can Retatrutide be substituted for Semaglutide in an experiment?

No substitution guidance is provided. Material selection belongs to the validated protocol of the receiving laboratory, which should be based on published specifications and the COA for the specific lot. VaultLabs supplies reference materials and documentation only.

Does this comparison include human outcome data?

No. It describes catalog specifications, supplied form, storage requirements and published research categories. VaultLabs does not provide medical, dosing or human-use information for any compound.

Compound comparison

Retatrutide vs Semaglutide

Retatrutide and Semaglutide are both catalogued under metabolic pathway research, which is why laboratories often weigh one against the other. This page compares their published specifications, supplied form, storage requirements and VaultLabs catalog status side by side. Specifications and research context only — no dosing, protocol or human-use guidance.

Research use only. For in vitro research use only. Not for human or animal consumption. Not for human consumption, medical use, or personal application.

Attribute	Retatrutide	Semaglutide
Category	Metabolic pathway research	Metabolic & incretin research
Compound type	Multi-receptor agonist peptide (research literature)	Incretin GLP-1 agonist peptide
CAS number (literature)	Not published	910463-68-2 (literature)
Supplied form	Lyophilized powder (GLP-3 RT 10 mg / 20 mg presentations)	Lyophilized powder
Appearance	White to off-white lyophilized material	White to off-white lyophilized material
Storage temperature	2–8 °C (lyophilized, sealed)	2–8 °C (lyophilized, sealed)
Primary research area	Receptor binding assays	GLP-1 receptor binding and signalling assays
Also referenced as	GLP-3 RT, Reta, RETA (colloquial for retatrutide)	GLP-1 receptor agonist peptide, NN9535
Batch verification	Lot lookup available	Lot lookup available
VaultLabs catalog	2 catalog SKUs	1 catalog SKU

Shared research areas

Receptor binding assays
In vitro receptor pharmacology

Key differences

Material type differs — Retatrutide is supplied as multi-receptor agonist peptide (research literature), Semaglutide as incretin glp-1 agonist peptide.
Presentation differs — Lyophilized powder (GLP-3 RT 10 mg / 20 mg presentations) vs Lyophilized powder.
Primary literature focus — Receptor binding assays vs GLP-1 receptor binding and signalling assays.

Storage comparison

Both are stored at 2–8 °C (lyophilized, sealed), so they can share the same cold-chain and inventory conditions. Retatrutide: 2–8 °C · protect from light. Semaglutide: 2–8 °C sealed lyophilized storage.

FAQ

Catalog availability

Presentations VaultLabs currently lists, dispatched from the UAE. Check the lot against batch verification before ordering.

Retatrutide

Semaglutide

semaglutide 30mg

Retatrutide overview Semaglutide overview All comparisons